Potentially hazardous co-prescribing of beta-adrenoceptor antagonists and agonists in the community.

Potentially hazardous co-prescribing of beta-agonists and beta-antagonists occurs despite labelled warnings, even in patients who appear to be at high risk. These events are quite rare but probably should not occur at all.